• C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Источник: Buzz FX / 14 янв 2025 05:15:17   America/New_York


    C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Shares of C4 Therapeutics, Inc. ( NASDAQ:CCCC - Get Free Report ) have be
    Read more...
Опубликовать